Beijing Chest Hospital

Beijing Chest Hospital: A National Medical Center Safeguarding Respiratory and Thoracic Health

Affiliated with Capital Medical University, Beijing Chest Hospital (Beijing Institute of Tuberculosis and Thoracic Oncology) is a Grade A tertiary specialized hospital directly under the Beijing Municipal Health Commission. It serves as the core unit of the National Clinical Research Center for Infectious Diseases and the designated hospital for the Beijing Municipal Tuberculosis Prevention and Control Center. Founded in 1955 as the Central Institute of Tuberculosis, the hospital has evolved over nearly seven decades into a nationally leading and internationally renowned institution integrating medical care, education, research, and prevention. It stands as a dual-field benchmark in tuberculosis and thoracic oncology treatment, serving patients from all 31 provinces (autonomous regions and municipalities) across China and over 50 countries worldwide. With annual outpatient visits exceeding 1.2 million, it performs over 15,000 surgeries annually. It holds a distinguished reputation in the diagnosis and treatment of complex and severe tuberculosis and thoracic tumors.

I. Hospital Profile: A National Cornerstone Dedicated to “Thoracic and Pulmonary Health”

Located at No. 9 Beiguan Street, Tongzhou District, Beijing, adjacent to the Grand Canal core area, the hospital spans a total floor area of approximately 230,000 square meters. It operates over 1,600 beds and employs more than 2,800 staff members, including over 400 senior-level specialists and over 120 doctoral/master's supervisors. The hospital houses two core disciplinary clusters—“Tuberculosis” and “Thoracic Oncology”—alongside supporting departments including Respiratory and Critical Care Medicine, Radiology, and Pathology. It hosts national/provincial-level key laboratories such as the National Clinical Research Center for Tuberculosis and the Beijing Engineering Research Center for Thoracic Oncology Diagnosis and Treatment. As a doctoral/master's training base for Respiratory Medicine, Oncology, and Tuberculosis at Capital Medical University, it cultivates hundreds of specialized professionals nationwide annually.

II. Technical Advantages: Dual Breakthroughs from “Tuberculosis Conquest” to “Precision Oncology”

Guided by the mission to “solve complex challenges and lead innovation,” the hospital has established a comprehensive, precision-oriented technical system in tuberculosis and thoracic oncology:

• Tuberculosis Diagnosis and Treatment: The “Chinese Solution” for Global Drug-Resistant TB

For challenging conditions like multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB), the hospital pioneered a comprehensive treatment approach combining “individualized regimen design + immunomodulation + complementary traditional Chinese medicine.” This elevated the success rate for treating drug-resistant TB from 50% to 75%. Innovative “bronchoscopic interventional techniques” (e.g., balloon dilation, cryoablation) have increased airway patency rates to over 90% in severe bronchial tuberculosis patients. Leveraging the National Tuberculosis Reference Laboratory, rapid detection of Mycobacterium tuberculosis (MTB) and over 20 drug resistance genes is achieved within 24 hours, with 99% diagnostic accuracy.

• Thoracic Oncology Care: “Minimally Invasive + Precision” Redefining Outcomes

Thoracic Surgery performs minimally invasive procedures including “single-port thoracoscopic lung cancer resection” and “combined thoraco-laparoscopic esophageal cancer resection,” with over 85% of surgeries being minimally invasive, reducing average postoperative hospital stays to 5 days; The Oncology Department implements a multidisciplinary team (MDT) model, developing personalized treatment plans combining surgery, targeted therapy, and immunotherapy for non-small cell lung cancer and esophageal cancer. This approach has increased the 5-year survival rate for advanced lung cancer by 30% compared to traditional treatments. The Radiation Oncology Department has introduced equipment such as Tomotherapy (TOMO) and CyberKnife, enabling precise irradiation of tumor targets while reducing damage to normal tissues by 40%.

• Critical Care: “Full-Cycle Management” Fortifies the Lifeline

The Department of Pulmonary and Critical Care Medicine (PCCM) utilizes ECMO (extracorporeal membrane oxygenation) and high-frequency oscillatory ventilation to successfully treat numerous severe pneumonia and acute respiratory distress syndrome (ARDS) patients. The Tuberculosis Emergency Department provides 24/7 care for critical cases like massive hemoptysis and tuberculous meningitis, achieving over 95% success in massive hemoptysis rescue.

III. Leading Specialties: Core Disciplines Covering the Full Spectrum of Prevention, Diagnosis, Treatment, and Rehabilitation

The hospital boasts six National Key Clinical Specialties (Tuberculosis Department, Thoracic Surgery, Medical Oncology, Respiratory and Critical Care Medicine, Radiology, Pathology), including:

• Tuberculosis Department: One of China's largest tuberculosis specialty centers, treating over 30,000 tuberculosis patients annually. It possesses extensive expertise in managing complex cases such as pediatric tuberculosis, tuberculosis during pregnancy, and extrapulmonary tuberculosis (including bone and brain tuberculosis). It has ranked first in tuberculosis treatment on the Fudan University “China Hospital Specialty Ranking” for ten consecutive years.

• Thoracic Surgery: A National Key Specialty excelling in complex surgical treatments for lung cancer (including central-type lung cancer and cases involving major vessels), esophageal cancer (such as cardia cancer), and mediastinal tumors. The department ranks among the nation's leaders in both surgical volume and complexity, achieving a 98% success rate for high-difficulty procedures like “Thoracoscopic Bronchopulmonary Double Sleeve Resection.”

• Medical Oncology: A Beijing Key Discipline focused on precision treatment for thoracic tumors. It leads nationally in lung cancer targeted therapy (e.g., EGFR/ALK mutation-targeted drugs), immunotherapy (PD-1/PD-L1 inhibitors), and post-drug-resistance strategies, spearheading multiple international multicenter clinical trials.

• Pulmonary and Critical Care Medicine (PCCM): A national model unit for standardized PCCM development, demonstrating exceptional expertise in managing common conditions like chronic obstructive pulmonary disease (COPD), asthma, and interstitial lung disease, as well as critical emergencies such as severe pneumonia and respiratory failure.

IV. Departmental Structure: Comprehensive Patient Care

Beyond core specialties, the hospital houses:

• Infectious Diseases Department (treating non-tuberculous mycobacterial infections, fungal infections, etc.)

• Radiation Oncology Department (precision radiotherapy for thoracic tumors)

• Pathology Department (conducting tuberculous granuloma and tumor molecular pathology diagnostics)

• Interventional Radiology Department (bronchial artery embolization for massive hemoptysis, tumor ablation) and Rehabilitation Medicine (postoperative respiratory function training, oncology rehabilitation). Supported by auxiliary departments like the Laboratory Center (tuberculosis culture, genetic testing) and Radiology (multi-slice spiral CT, PET-CT), these form an integrated “diagnosis-treatment-rehabilitation” service network.

V. Medical Equipment: World-Class Devices Empowering Precision Care

The hospital is equipped with globally leading medical devices to support the diagnosis and treatment of complex and critical conditions:

• Tuberculosis Diagnostics: Roche (Germany) fully automated TB culture system, BD (Becton Dickinson, USA) MGIT 960 liquid culture system (gold standard for rapid TB detection), BioMérieux (France) Xpert MTB/RIF genetic analyzer (2-hour detection of TB and rifampicin resistance).

• Oncology Equipment: Siemens PET-CT (Germany) for early tumor screening and staging; Philips Ingenia 3.0T MRI (Netherlands) for precise imaging of neurological and mediastinal lesions; Varian TrueBeam linear accelerator (USA) for high-precision radiotherapy; Da Vinci surgical robot (USA) for thoracoscopic minimally invasive surgery.

• Emergency and Critical Care Equipment: Germany's Maquet ECMO (extracorporeal membrane oxygenation for life support), USA's Tyco high-frequency oscillatory ventilator (for ARDS treatment), Japan's Olympus electronic bronchoscope (2.8mm ultra-thin diameter, suitable for pediatric and critically ill patients).

VI. International Patient Services: Global Healthcare with a “Chinese Touch”

As a “World Health Organization (WHO) Collaborating Center for Tuberculosis,” the hospital serves as a key referral destination for tuberculosis patients from Southeast Asia, the Middle East, Africa, and other regions, offering comprehensive convenience services for international patients:

• Multilingual Support: An International Medical Department staffed with professional translators fluent in English, Arabic, Spanish, and other languages. Medical personnel can communicate in basic foreign languages. Key examination reports (e.g., CT scans, pathology) are provided in English.

• One-Stop Service: Assistance with registration, appointment scheduling, medical record translation, visa extensions, and other procedures. Priority access to care (emergency patients seen within 30 minutes).

• International Insurance Coverage: Partnering with global insurers like MSH (Wanxinhe) and Cigna to support direct billing for overseas medical plans, enabling international credit card payments and cross-border transactions.

• Cultural Adaptation Services: Providing diverse dietary options, including halal and vegetarian meals in wards; respecting religious customs (e.g., Islamic prayer times, Christian holiday observances); offering dedicated religious activity rooms.

• Telemedicine: Collaborations with Johns Hopkins Hospital (USA) and London Chest Hospital (UK) enable video-linked international expert consultations for complex cases.

VII. International Patient Testimonials: “Professionalism heals the body; warmth heals the soul”

• Ali (32, multidrug-resistant tuberculosis, Pakistan): “After two years of ineffective treatment in Pakistan, doctors here adjusted my regimen based on genetic testing. My sputum culture turned negative within three months. Nurses taught me daily symptom tracking in Chinese and provided an English-language TB medication handbook upon discharge.”

• Emily (45, lung adenocarcinoma, USA): “The thoracic surgeon performed my lung cancer surgery using the Da Vinci robot with only a 3cm incision. I was able to get out of bed the day after surgery. The oncology team designed an immunotherapy-combined-chemotherapy regimen for me. Now my tumor has shrunk by 60%—it's truly amazing!”

• Rina (28, lymphatic tuberculosis with HIV, Indonesia): " The infectious disease specialists not only treated my tuberculosis but also helped control my HIV viral load. The ward has dedicated privacy protection measures, and the medical staff never disclosed my condition, which gave me great peace of mind."

VIII. Contact Information and Transportation Guide

• Hospital Address: No. 9 Beiguan Street, Tongzhou District, Beijing (Main Campus of Beijing Chest Hospital Affiliated to Capital Medical University).

• Consultation Hotline: 010-89509100 (Main Switchboard), 010-89509000 (International Patient Service Line).

• WeChat Official Account: Search “Beijing Chest Hospital Service Account” for online appointments, report inquiries, and access tuberculosis/cancer prevention resources.

• Transportation Routes:

• Subway: Exit B at Beiyunhe West Station (Line 6), 8-minute walk;

• Bus: Take routes 317, 649, 807, etc., to Beijing Chest Hospital Station;

• Driving: Underground parking available (6 RMB/hour). Nearby parking at Wanda Plaza Tongzhou (10-minute walk).

Beijing Chest Hospital upholds the mission of “Safeguarding Lives, Precision for Success.” With its deep expertise in tuberculosis and thoracic oncology, continuous technological innovation, and compassionate care for patients worldwide, it remains a trusted guardian of thoracic health. Whether providing standardized treatment for common tuberculosis and thoracic tumors or tackling complex critical cases through multidisciplinary collaboration, the hospital delivers high-quality, compassionate medical services to global patients with “Chinese wisdom.”

Document dated 2025-09-15 14:44 Modify